Literature DB >> 32070094

Photochromic evaluation of 3(5)-arylazo-1H-pyrazoles.

Karin Rustler, Philipp Nitschke, Sophie Zahnbrecher, Julia Zach, Stefano Crespi, Burkhard König.   

Abstract

The desire to photocontrol molecular properties ranging from materials to pharmacology using light as an external trigger with high spatiotemporal resolution lead to the development of a broad range of photochromic scaffolds. Amongst them, azobenzenes are synthetically well accessible and show excellent fatigue resistance. Their photochromic properties vary with the substitution pattern and for different heteroarenes. However, the photochromism of 3(5)-substituted-1H-pryazoles has not yet been investigated although this compound class offers interesting possibilities of metal ion coordination and hydrogen bond formation via its NH-moiety. Herein, we present the results of an experimental and computational investigation of arylazo-3(5)-arylazo-1H-pyrazoles. To elucidate their properties, solvent and substitution effects on their light absorption, thermal half-lives, photostationary states (PSS), fatigue and quantum yields were determined.

Entities:  

Year:  2020        PMID: 32070094     DOI: 10.1021/acs.joc.9b03097

Source DB:  PubMed          Journal:  J Org Chem        ISSN: 0022-3263            Impact factor:   4.354


  3 in total

Review 1.  Molecular photoswitches in aqueous environments.

Authors:  Jana Volarić; Wiktor Szymanski; Nadja A Simeth; Ben L Feringa
Journal:  Chem Soc Rev       Date:  2021-11-15       Impact factor: 54.564

2.  Synthesis and photochromism of catechol-containing symmetrical azobenzene compounds.

Authors:  Suju Fan; Yintung Lam; Liang He; John H Xin
Journal:  R Soc Open Sci       Date:  2022-06-08       Impact factor: 3.653

3.  Photoswitchable Azo- and Diazocine-Functionalized Derivatives of the VEGFR-2 Inhibitor Axitinib.

Authors:  Linda Heintze; Dorian Schmidt; Theo Rodat; Lydia Witt; Julia Ewert; Malte Kriegs; Rainer Herges; Christian Peifer
Journal:  Int J Mol Sci       Date:  2020-11-25       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.